Ç. TEKİN Et Al. , "Investigation of Anti-cancer Properties of 2,2,4,4-Tetra (4 '-oxy-substituted-chalcone)-6,6-diphenylcyclotriphosphazene Derivatives Against Human Ovarian (A2780) and Prostate (PC-3) Cancer Cell Lines," ACTA PHYSIOLOGICA , vol.218, pp.51, 2016
TEKİN, Ç. Et Al. 2016. Investigation of Anti-cancer Properties of 2,2,4,4-Tetra (4 '-oxy-substituted-chalcone)-6,6-diphenylcyclotriphosphazene Derivatives Against Human Ovarian (A2780) and Prostate (PC-3) Cancer Cell Lines. ACTA PHYSIOLOGICA , vol.218 , 51.
TEKİN, Ç., Koran, K., TEKİN, S., SANDAL, S., & Gorgulu, A. O., (2016). Investigation of Anti-cancer Properties of 2,2,4,4-Tetra (4 '-oxy-substituted-chalcone)-6,6-diphenylcyclotriphosphazene Derivatives Against Human Ovarian (A2780) and Prostate (PC-3) Cancer Cell Lines. ACTA PHYSIOLOGICA , vol.218, 51.
TEKİN, ÇİĞDEM Et Al. "Investigation of Anti-cancer Properties of 2,2,4,4-Tetra (4 '-oxy-substituted-chalcone)-6,6-diphenylcyclotriphosphazene Derivatives Against Human Ovarian (A2780) and Prostate (PC-3) Cancer Cell Lines," ACTA PHYSIOLOGICA , vol.218, 51, 2016
TEKİN, ÇİĞDEM Et Al. "Investigation of Anti-cancer Properties of 2,2,4,4-Tetra (4 '-oxy-substituted-chalcone)-6,6-diphenylcyclotriphosphazene Derivatives Against Human Ovarian (A2780) and Prostate (PC-3) Cancer Cell Lines." ACTA PHYSIOLOGICA , vol.218, pp.51, 2016
TEKİN, Ç. Et Al. (2016) . "Investigation of Anti-cancer Properties of 2,2,4,4-Tetra (4 '-oxy-substituted-chalcone)-6,6-diphenylcyclotriphosphazene Derivatives Against Human Ovarian (A2780) and Prostate (PC-3) Cancer Cell Lines." ACTA PHYSIOLOGICA , vol.218, p.51.
@article{article, author={ÇİĞDEM TEKİN Et Al. }, title={Investigation of Anti-cancer Properties of 2,2,4,4-Tetra (4 '-oxy-substituted-chalcone)-6,6-diphenylcyclotriphosphazene Derivatives Against Human Ovarian (A2780) and Prostate (PC-3) Cancer Cell Lines}, journal={ACTA PHYSIOLOGICA}, year=2016, pages={51} }